Serum deprivation elevates the levels of microvesicles with different size distributions and selectively enriched proteins in human myeloma cells in vitro

Acta Pharmacol Sin. 2014 Mar;35(3):381-93. doi: 10.1038/aps.2013.166. Epub 2013 Dec 30.

Abstract

Aim: To investigate the effects of serum deprivation (SD) on microvesicles (MVs) secreted from human myeloma cells and the implications for disease progression.

Methods: RPMI 8226, U266, and KM3 human myeloma cells were incubated in medium containing 10% (non-SD) or 1% fetal bovine serum (SD) and MVs were isolated. The levels and size distribution of MVs were analyzed with flow cytometry. The protein profiles of MVs were studied using 2D SDS-PAGE, MALDI-TOF-MS, and Western blotting. NF-κB activation was analyzed using EMSA. Angiogenesis was examined in Eahy926 endothelial cells.

Results: Exposure of RPMI 8226 cells to SD for 24 h did not alter the number of apoptotic cells. However, SD increased the number of MVs from RPMI 8226, U266, and KM3 cells to 2.5-, 4.3-, and 3.8-fold, respectively. The size distribution of SD MVs was also significantly different from that of non-SD MVs. Three proteins ZNF224, SARM, and COBL in SD MVs were found to be up-regulated, which were involved in cell cycle regulation, signal transduction and metabolism, respectively. Co-culture of SD MVs and RPMI 8226 cells increased NF-κB activation in the target RPMI 8226 cells. Furthermore, SD MVs from RPMI 8226 cells significantly increased the microtubule formation capacity of Eahy926 endothelial cells compared with non-SD MVs.

Conclusion: SD elevates the levels of microvesicles with different size distribution and selectively enriched proteins in human myeloma cells in vitro. The selectively enriched proteins, especially ZNF224, may play key roles in regulation of myeloma cells, allowing better adaptation to SD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Autocrine Communication*
  • Blotting, Western
  • Cell Cycle Checkpoints
  • Cell Line, Tumor
  • Cell Proliferation
  • Cell-Derived Microparticles / metabolism*
  • Cell-Derived Microparticles / pathology
  • Coculture Techniques
  • Culture Media, Serum-Free / metabolism*
  • Electrophoresis, Gel, Two-Dimensional
  • Endothelial Cells / metabolism
  • Flow Cytometry
  • Humans
  • Multiple Myeloma / blood
  • Multiple Myeloma / metabolism*
  • Multiple Myeloma / pathology
  • Myeloma Proteins / metabolism*
  • NF-kappa B / metabolism
  • Neovascularization, Physiologic
  • Paracrine Communication*
  • Proteomics / methods
  • Repressor Proteins / metabolism
  • Signal Transduction
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Time Factors

Substances

  • Culture Media, Serum-Free
  • Myeloma Proteins
  • NF-kappa B
  • Repressor Proteins
  • ZNF224 protein, human